2017-2022 United States Postmenopausal Vaginal Atrophy Treatment Market Report (Status and Outlook)

October 2017 | 112 pages | ID: 2864529F74EEN
LP Information

Abstracts

In 2016, the Postmenopausal Vaginal Atrophy Treatment market size was xx million USD in United States, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022.

In United States market, the top players include

• Pfizer
• Allergan
• Shionogi
• Novo Nordisk
• Teva Pharmaceutical
• Bayer.

Split by product types/category, covering

• Creams
• Tablets
• Patches
• Rings

Split by applications/end use industries, covers

• Topical Estrogen
• Systemic Estrogen
• Non-hormonal Therapy

Contents

1 POSTMENOPAUSAL VAGINAL ATROPHY TREATMENT MARKET OVERVIEW

1.1 Product Overview and Scope of Postmenopausal Vaginal Atrophy Treatment
1.2 Postmenopausal Vaginal Atrophy Treatment Market Segment by Types
  1.2.1 United States Postmenopausal Vaginal Atrophy Treatment Sales Present Situation and Outlook by Types (2012-2022)
  1.2.2 United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Types in 2016
  1.2.3 Creams
    1.2.3.1 Major Players of Creams
  1.2.4 Tablets
    1.2.4.1 Major Players of Tablets
  1.2.5 Patches
    1.2.5.1 Major Players of Patches
  1.2.6 Rings
    1.2.6.1 Major Players of Rings
1.3 United States Postmenopausal Vaginal Atrophy Treatment Market Segment by Applications/End Use Industries
  1.3.1 United States Postmenopausal Vaginal Atrophy Treatment Sales Present Situation and Outlook by Applications/End Industrials (2012-2022)
  1.3.2 United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Applications in 2016
  1.3.2 Topical Estrogen
  1.3.3 Systemic Estrogen
  1.3.4 Non-hormonal Therapy
1.4 United States Postmenopausal Vaginal Atrophy Treatment Overview and Market Size (Value) (2012-2022)
  1.4.1 United States Market Postmenopausal Vaginal Atrophy Treatment Overview
  1.4.2 United States Postmenopausal Vaginal Atrophy Treatment Market Size (Value and Volume) Status and Forecast (2012-2022)

2 UNITED STATES POSTMENOPAUSAL VAGINAL ATROPHY TREATMENT SALES, REVENUE (VALUE) AND MARKET SHARE BY PLAYERS

2.1 United States Postmenopausal Vaginal Atrophy Treatment Sales and Market Share (2012-2017) by Players
2.2 United States Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Players (2012-2017)
2.3 United States Postmenopausal Vaginal Atrophy Treatment Average Price by Players in 2016
2.4 United States Postmenopausal Vaginal Atrophy Treatment Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 Postmenopausal Vaginal Atrophy Treatment Market Competitive Situation and Trends
  2.5.1 Postmenopausal Vaginal Atrophy Treatment Market Concentration Rate
  2.5.2 Postmenopausal Vaginal Atrophy Treatment Market Share of Top 3 and Top 5 Players
  2.5.3 Mergers & Acquisitions, Expansion

3 UNITED STATES POSTMENOPAUSAL VAGINAL ATROPHY TREATMENT SALES, REVENUE (VALUE) BY TYPE AND APPLICATION (2012-2017)

3.1 United States Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Market Share and Price by Type (2012-2017)
  3.1.1 United States Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type (2012-2017)
  3.1.2 United States Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Type (2012-2017)
  3.1.3 United States Postmenopausal Vaginal Atrophy Treatment Price by Type (2012-2017)
3.2 United States Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Application (2012-2017)
3.3 United States Market Postmenopausal Vaginal Atrophy Treatment Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)

4 UNITED STATES POSTMENOPAUSAL VAGINAL ATROPHY TREATMENT PLAYERS PROFILES AND SALES DATA

4.1 Pfizer
  4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.1.2 Postmenopausal Vaginal Atrophy Treatment Product Types, Application and Specification
    4.1.2.1 Type
    4.1.2.2 Type
  4.1.3 Pfizer Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  4.1.4 Main Business/Business Overview
  4.1.5 Pfizer News
4.2 Allergan
  4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.2.2 Postmenopausal Vaginal Atrophy Treatment Product Types, Application and Specification
    4.2.2.1 Type
    4.2.2.2 Type
  4.2.3 Allergan Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  4.2.4 Main Business/Business Overview
  4.2.5 Allergan News
4.3 Shionogi
  4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.3.2 Postmenopausal Vaginal Atrophy Treatment Product Types, Application and Specification
    4.3.2.1 Type
    4.3.2.2 Type
  4.3.3 Shionogi Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  4.3.4 Main Business/Business Overview
  4.3.5 Shionogi News
4.4 Novo Nordisk
  4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.4.2 Postmenopausal Vaginal Atrophy Treatment Product Types, Application and Specification
    4.4.2.1 Type
    4.4.2.2 Type
  4.4.3 Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  4.4.4 Main Business/Business Overview
  4.4.5 Novo Nordisk News
4.5 Teva Pharmaceutical
  4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.5.2 Postmenopausal Vaginal Atrophy Treatment Product Types, Application and Specification
    4.5.2.1 Type
    4.5.2.2 Type
  4.5.3 Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  4.5.4 Main Business/Business Overview
  4.5.5 Teva Pharmaceutical News
4.6 Bayer.
  4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.6.2 Postmenopausal Vaginal Atrophy Treatment Product Types, Application and Specification
    4.6.2.1 Type
    4.6.2.2 Type
  4.6.3 Bayer. Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  4.6.4 Main Business/Business Overview
  4.6.5 Bayer. News

5 UNITED STATES POSTMENOPAUSAL VAGINAL ATROPHY TREATMENT MARKET FORECAST (2017-2022)

5.1 United States Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Price Forecast (2017-2022)
  5.1.1 United States Postmenopausal Vaginal Atrophy Treatment Sales and Growth Rate Forecast (2017-2022)
  5.1.2 United States Postmenopausal Vaginal Atrophy Treatment Revenue and Growth Rate Forecast (2017-2022)
  5.1.3 United States Postmenopausal Vaginal Atrophy Treatment Price Trend Forecast (2017-2022)
5.2 United States Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Type (2017-2022)
5.3 United States Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Application (2017-2022)

6 PRODUCTION COST ANALYSIS OF POSTMENOPAUSAL VAGINAL ATROPHY TREATMENT

6.1 Main Raw Materials of Postmenopausal Vaginal Atrophy Treatment
  6.1.1 List of Postmenopausal Vaginal Atrophy Treatment Main Raw Materials
  6.1.2 Postmenopausal Vaginal Atrophy Treatment Main Raw Materials Price Analysis
  6.1.3 Postmenopausal Vaginal Atrophy Treatment Raw Materials Major Suppliers
  6.1.4 Postmenopausal Vaginal Atrophy Treatment Main Raw Materials Market Concentration Rate
6.2 Production Cost Structure of Postmenopausal Vaginal Atrophy Treatment
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Production Expenses
6.3 Postmenopausal Vaginal Atrophy Treatment Manufacturing Process/Method

7 VALUE CHAIN, PURCHASING STRATEGY AND DOWNSTREAM BUYERS

7.1 Postmenopausal Vaginal Atrophy Treatment Value Chain Analysis
7.2 Upstream Raw Materials Purchasing
7.3 Raw Materials Sources of Postmenopausal Vaginal Atrophy Treatment Major Players in 2016
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Sales Channel
  8.1.1 Direct Sales
  8.1.2 Indirect Sales
  8.1.3 Sales Channel Development Trend
8.2 Product Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Postmenopausal Vaginal Atrophy Treatment Distributors/Traders List in United States

9 MARKET INFLUENCES FACTORS ANALYSIS

9.1 Changes from the Related Industries
9.2 Substitutes Threat
9.3 Customer Preference Change
9.4 Economic/Political Environmental Change
9.5 Upstream and Downstream Fluctuation

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Postmenopausal Vaginal Atrophy Treatment
Table Product Specifications of Postmenopausal Vaginal Atrophy Treatment
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales (volume) for Each Type (2012-2022)
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Types in 2016
Table Types of Postmenopausal Vaginal Atrophy Treatment
Figure Product Picture of Creams
Table Major Players of Creams
Figure Product Picture of Tablets
Table Major Players of Tablets
Figure Product Picture of Patches
Table Major Players of Patches
Figure Product Picture of Rings
Table Major Players of Rings
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Present Situation and Outlook by Applications (2012-2022)
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Applications in 2016
Table Applications of Postmenopausal Vaginal Atrophy Treatment
Figure Topical Estrogen Examples
Figure Systemic Estrogen Examples
Figure Non-hormonal Therapy Examples
Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) Status and Forecast (2012-2022)
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales (Volume) Status and Forecast (2012-2022)
Table United States Postmenopausal Vaginal Atrophy Treatment Sales by Players (2012-2017)
Table United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share (%) by Players (2012-2017)
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Share by Players in 2016
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Share by Players in 2017
Table United States Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) by Players (2012-2017)
Table United States Postmenopausal Vaginal Atrophy Treatment Revenue Market Share (%) by Players (2012-2017)
Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue Share by Players in 2016
Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue Share by Players in 2017
Figure United States Postmenopausal Vaginal Atrophy Treatment Average Price by Players in 2016
Table United States Postmenopausal Vaginal Atrophy Treatment Manufacturing Base Distribution and Sales Area by Players
Table Players Postmenopausal Vaginal Atrophy Treatment Product Types
Figure Postmenopausal Vaginal Atrophy Treatment Market Share of Top 3 Players
Figure Postmenopausal Vaginal Atrophy Treatment Market Share of Top 5 Players
Table United States Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017)
Table United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017)
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type 2016
Figure 2016 United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type
Table United States Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) by Type (2012-2017)
Table United States Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type (2012-2017)
Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type 2016
Figure 2016 United States Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Type
Table United States Postmenopausal Vaginal Atrophy Treatment Price by Type (2012-2017)
Table United States Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017)
Table United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017)
Figure 2016 United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application
Table United States Market Postmenopausal Vaginal Atrophy Treatment Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)
Table Pfizer Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Postmenopausal Vaginal Atrophy Treatment Market Share (2012-2017)
Table Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Allergan Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Allergan Postmenopausal Vaginal Atrophy Treatment Market Share (2012-2017)
Table Shionogi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shionogi Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Shionogi Postmenopausal Vaginal Atrophy Treatment Market Share (2012-2017)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Market Share (2012-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Market Share (2012-2017)
Table Bayer. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer. Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer. Postmenopausal Vaginal Atrophy Treatment Market Share (2012-2017)
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales and Growth Rate Forecast (2017-2022)
Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue and Growth Rate Forecast (2017-2022)
Figure United States Postmenopausal Vaginal Atrophy Treatment Price Trend Forecast (2017-2022)
Table United States Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Type (2017-2022)
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share Forecast by Type (2017-2022)
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share Forecast by Type in 2022
Table United States Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Application (2017-2022)
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share Forecast by Application (2017-2022)
Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share Forecast by Application in 2022
Table Production Base and Market Concentration Rate of Raw Material
Figure Postmenopausal Vaginal Atrophy Treatment Main Raw Materials Price Trend
Table Postmenopausal Vaginal Atrophy Treatment Raw Materials Major Suppliers List
Figure Production Cost Structure of Postmenopausal Vaginal Atrophy Treatment
Figure Postmenopausal Vaginal Atrophy Treatment Manufacturing Process/Method
Figure Postmenopausal Vaginal Atrophy Treatment Value Chain Analysis
Table Raw Materials Sources of Postmenopausal Vaginal Atrophy Treatment Major Players in 2016
Table Major Buyers of Postmenopausal Vaginal Atrophy Treatment
Table Postmenopausal Vaginal Atrophy Treatment Distributors/Traders List in United States